MetLife, Inc.
MET
$78.02
$0.4250.55%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 17.60B | 18.94B | 16.92B | 17.77B | 16.41B |
| Total Other Revenue | 972.00M | -280.00M | 1.52B | 56.00M | -357.00M |
| Total Revenue | 18.57B | 18.66B | 18.44B | 17.82B | 16.06B |
| Cost of Revenue | 13.57B | 14.69B | 12.65B | 13.62B | 12.49B |
| Gross Profit | 5.00B | 3.97B | 5.79B | 4.20B | 3.57B |
| SG&A Expenses | -- | -- | -- | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 3.09B | 3.10B | 3.01B | 2.92B | 2.95B |
| Total Operating Expenses | 16.66B | 17.79B | 15.66B | 16.55B | 15.44B |
| Operating Income | 1.91B | 871.00M | 2.78B | 1.28B | 615.00M |
| Income Before Tax | 1.35B | 1.38B | 1.99B | 1.20B | 1.05B |
| Income Tax Expenses | 404.00M | 106.00M | 653.00M | 249.00M | 170.00M |
| Earnings from Continuing Operations | 950.00M | 1.28B | 1.34B | 953.00M | 875.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -5.00M | -4.00M | 1.00M | -7.00M | -8.00M |
| Net Income | 945.00M | 1.27B | 1.34B | 946.00M | 867.00M |
| EBIT | 1.91B | 871.00M | 2.78B | 1.28B | 615.00M |
| EBITDA | 1.94B | 1.49B | 2.81B | 1.31B | 644.00M |
| EPS Basic | 1.29 | 1.79 | 1.82 | 1.28 | 1.11 |
| Normalized Basic EPS | 1.23 | 1.24 | 1.78 | 1.05 | 0.89 |
| EPS Diluted | 1.28 | 1.78 | 1.81 | 1.28 | 1.10 |
| Normalized Diluted EPS | 1.22 | 1.23 | 1.77 | 1.04 | 0.89 |
| Average Basic Shares Outstanding | 682.30M | 693.00M | 699.30M | 710.50M | 723.20M |
| Average Diluted Shares Outstanding | 687.00M | 697.90M | 703.70M | 714.70M | 728.40M |
| Dividend Per Share | 0.55 | 0.55 | 0.55 | 0.55 | 0.52 |
| Payout Ratio | 46.56% | 32.26% | 33.53% | 44.71% | 51.21% |